Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ori Biotech, a UK-based cell and gene therapy manufacturing spinout of University College London, closed a £7m ($9.4m) seed round yesterday backed by Amadeus Capital Partners, Delin Ventures and Kindred Capital together with an unnamed family office and undisclosed existing angel investors. The spinout was founded in 2015 by Chris Mason and Farlan Veraitch, professor…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.